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	 Introduction	
A. 	 baumannii	 (Ab)	 has	 recently	 emerged	 as	 a	 leading	 cause	 of	 nosocomial	 infec4ons,	
mainly	 aﬀec4ng	 debilitated	 individuals	 staying	 in	 Intensive	 Care	 Units.	 Ab	 infec4ons	
o=en	 represent	 a	 serious	 therapeu4c	 issue,	 due	 to	 the	 high	 frequency	 of	 mul4drug-
resistant	 strains.	Addi4onally,	most	Ab	 isolates	 form	bioﬁlms,	 that	may	 further	hinder	
an4microbial	therapy.	Bioﬁlms	are	communi4es	of	bacteria	aDached	to	a	surface	and/or	
to	 each	 other	 and	 embedded	 in	 an	 extracellular	matrix	 of	 polymeric	material,	whose	
composi4on	varies	depending	on	the	bacterial	species	and	on	the	strain.	
Aim of the study	
The	development	of	 new	an4microbials	 eﬀec4ve	against	 both	planktonic	 and	bioﬁlm-
grown	Ab	would	be	extremely	useful.	In	this	study,	we	tested	two	an4microbial	pep4des	
(AMPs),	namely	Bac7(1-35)	and	BMAP-27	(Fig.	1),	against	a	panel	of	Ab	clinical	isolates	
diﬀering	in	lineage	and	bioﬁlm-forming	ability.	
Results	
	
•  The	Bioﬁlm	Inhibitory	Concentra4ons	(BICs)	were	up	to	32	4mes	higher	than	the	
Minimal	 Inhibitory	 Concentra4ons	 (MICs)	 of	 planktonic	 cells.	 Scarce	 bioﬁlm	
producers	 showed	 lower	 BICs,	 sugges4ng	 that	 lower	 suscep4bility	 to	 AMPs	 is	
related	to	the	produc4on	of	an	abundant	bioﬁlm	layer	(Tab.	1).	
•  Killing	of	bioﬁlm	embedded	cells	was	studied	on	strains	3B	and	420,	which	are	
an	 excellent	 and	 a	 scarce	 bioﬁlm	 producer,	 respec4vely.	 Both	 pep4des	 were	
more	ac4ve	against	the	scarce	producer	Ab	420	(Fig.	2).	 Indeed,	BMAP-27	was	
almost	inac4ve	against	the	excellent	bioﬁlm	producer	Ab	3B.	
•  Both	pep4des	were	more	ac4ve	against	a	newly	formed	(6	hours)	bioﬁlm	than	
against	 a	 well	 established	 (24	 hours)	 one.	 This	 result	 suggests	 that	 bioﬁlm	
matura4on	plays	an	important	role,	perhaps	through	matrix	produc4on	(Fig.	2).		
•  To	 test	 the	 laDer	 hypothesis,	MIC	 assays	were	 repeated	 in	 the	 presence	 of	 a	
crude	matrix	prepara4on.	Matrix	addi4on	caused	a	8-16x	 increase	of	the	MICs	
of	both	pep4des	(Tab.	2).	The	same	eﬀect	could	be	observed	for	the	MIC	values	
of	 the	 an4bio4c	 colis4n	 and,	 to	 a	 lesser	 extent,	 of	 tobramycin,	 but	 not	 of	
ciproﬂoxacin,	the	smallest	an4microbial	molecule	tested.	
Conclusions	
	
Both	pep(des	have	a	good	ac(vity	against	planktonic	Ab,	but	bioﬁlm-
grown	bacteria	show	a	signiﬁcant	decrease	of	suscep(bility.	
	
It	appears	likely	that	the	A.	baumannii	bioﬁlm	matrix,	at	least	the	one	
produced	by	strain	Ab	3B,		decreases	or	delays	access	of	pep(des	and	
larger	an(microbials	to	bacterial	cells.	 	
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Table 1. AMPs activity against planktonic and sessile 	
A. baumannii	
Fig. 2. Killing activity of AMPs on A. baumannii bioﬁlm-
embedded cells 	
Fig. 1. Structure and mechanism of action of Bac7(1-35)	
 and BMAP-27	
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Bac7(1-35)	and	BMAP-27	are	bovine	AMPs	belonging	to	the	cathelicidin	family.	
Bac7(1-35)	is	the	1–35	fragment	of	the	Pro-rich	extended	bactenecin	Bac7,	which	
can	penetrate	into	suscep4ble	Gram-nega4ve	bacteria	and	inac4vate	cytoplasmic	
targets1,	while	BMAP-27	is	a	membranoly4c	pep4de	with	a	helical	ac4ve	form2.		
aMICs	were	assessed	by	the	broth	micro-dilui4on	method	following	the	CLSI	
speciﬁca4ons3.	bBICs	were	measured	as	described	by	Moskovitz4.	cBioﬁlm	
produc4on	was	assessed	by	the	colorimetric	crystal	violet-based	method5	and	
categorized	as	follows:	scarce:	OD<0,300;	good:	0,300<OD<0,600;	excellent:	
0,600<OD<0,950.	
strain' Crude'matrix''extracted'from'Ab'3B' Bac57(1535)'(µM)' BMAP527'(µM)' Tobramycin'(µg/ml)' Ciprofloxacin'(µg/ml)' Colistin'(µg/ml)'3B'' 5' 4' 4' 1' 2' 1'3B'' 0,1 mg/ml' 4' 8' 2' 2' 2'3B'' 1 mg/ml' 32' 64' 8' 2' 32'420'' 5' 4' 4' >512' 256' 0,5'420'' 0,1 mg/ml' 8' 8' ND' ND' 4'420'' 1 mg/ml' 32' 64' ND' ND' 32''
	
Table 2. AMPs activity against planktonic A. baumannii in 
the presence of a crude matrix preparation	
Matrix	was	extracted	from	Ab	3B	bioﬁlm	grown	on	cellulose	membranes	
deposited	on	Mueller-Hinton	agar	medium,	using	the	method	described	by	Bales	
et	al.6		
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Pep4des	were	added	at	the	indicated	concentra4ons	to	Ab	bioﬁlm	that	had	been	
developed	for	6	or	24	hours.	Bacterial	counts	at	4me	0	were	about	107.	Values	are	
the	mean	of	two	independent	experiments	performed	in	duplicate.	
